DIRECTMX
Live / Registered — Registered (as of 01 Dec 2020)
What this means for you
Registered since 01 Dec 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88614061
- Registration number
- 6208690
- Mark type
- Stylized text
- Filed
- 12 Sept 2019
- Published for opposition
- 15 Sept 2020
- Registered
- 01 Dec 2020
- Attorney of record
- Timothy P. Naill
Goods and services
- Class 001 — Chemicals: Biological preparations for use in industry; Biological preparations for use in science; Carriers for biologically active compounds; Biological substances, materials, preparations and elements for scientific and industrial use in vivo and in vitro; Chemical substances, chemical materials and chemical preparations, and natural elements for scientific and industrial use in vivo and in vitro; biological materials for use in industry and science; Chemical substances, materials, preparations and elements for cosmetic preparations; Biological substances, materials, preparations and elements for cosmetic preparations; Lipid nanoparticles for use in industry and science; Lipid nanoparticles comprising protein for use in industry and science; Saposin-lipid nanoparticles for use in industry and science
- Class 005 — Pharmaceuticals: Biochemical preparations for preventing or treating infectious or parasitic diseases, cancer, diseases of the blood and blood-forming organs, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye, diseases of the ear, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system and autoimmune diseases; Biochemical preparations for preventing or treating infectious or parasitic diseases, cancer, diseases of the blood and blood-forming organs, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye, diseases of the ear, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system and autoimmune diseases in non-human animals; Biological reagents for medical use; Biological reagents for veterinary use; Carriers for pharmaceutical, medical, veterinary or diagnostic compounds; Biochemical preparations for preventing or treating infectious or parasitic diseases, cancer, diseases of the blood and blood-forming organs, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye, diseases of the ear, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system and autoimmune diseases in humans and non-human animals and for use in a diagnostic method; Medicinal preparations and substances for preventing or treating infectious or parasitic diseases, cancer, diseases of the blood and blood-forming organs, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye, diseases of the ear, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system and autoimmune diseases in humans and non-human animals; Veterinary vaccines; Human vaccine preparations; Lipid nanoparticles for medicinal, diagnostic or pharmaceutical purposes; Lipid nanoparticles comprising protein for medical, diagnostic or pharmaceutical purposes; Saposin-lipid nanoparticles for medical, diagnostic or pharmaceutical purposes
- Class 040 — Treatment of materials: Treatment of cells and/or viruses and/or biological membranes to obtain carriers for biologically active, pharmaceutical or diagnostic compounds; Conversion of cells and/or viruses and/or biological membranes into biochemical preparations; Custom manufacturing of lipid nanoparticles in particular of lipid nanoparticles comprising protein or Saposin-lipid nanoparticles; Processing of cells and/or viruses and/or biological membranes for third parties
- Class 042 — Scientific and technological services: Biological laboratory services; Biochemistry consultancy; Consulting services in the field of lipid nanoparticles in particular in the field of lipid nanoparticles comprising protein or Saposin-lipid nanoparticles
Owner
- SALIPRO BIOTECH AB, Stockholm, SE
- SALIPRO BIOTECH AB, Stockholm, SE
- SALIPRO BIOTECH AB, Stockholm, SE
Prosecution history
- 01 Dec 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 01 Dec 2020 — REGISTERED-PRINCIPAL REGISTER
- 15 Sept 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Sept 2020 — PUBLISHED FOR OPPOSITION
- 26 Aug 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Aug 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Aug 2020 — EXAMINER'S AMENDMENT ENTERED
- 09 Aug 2020 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 09 Aug 2020 — EXAMINERS AMENDMENT E-MAILED
- 09 Aug 2020 — EXAMINERS AMENDMENT -WRITTEN
- 24 Jun 2020 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 24 Jun 2020 — LETTER OF SUSPENSION E-MAILED
- 24 Jun 2020 — SUSPENSION LETTER WRITTEN
- 15 Jun 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Jun 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE